GlassScriptPhysician profile
Hakam M Asaad
NPI 1871603241
$8,396.37
in general payments reported to CMS, 2019-2025
58 companies · $1,875 in 2025
The $1,875 reported for 2025 was more than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
See the full distribution for Neuromuscular Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $1,216 · 2022: $1,396 · 2023: $1,725 · 2024: $2,050 · 2025: $1,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,550 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,550.03 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,291.21 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Genentech USA, INC. | $801.05 | 2022-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Jazz Pharmaceuticals INC. | $417.35 | 2021-2025 | Xywav |
| Ucb, INC. | $399.55 | 2019-2025 | Briviact, Rystiggo |
| Biogen, INC. | $350.08 | 2021-2025 | Skyclarys, Spinraza |
| Grifols USA, LLC | $288.76 | 2022-2024 | Gamunex-C |
| Acadia Pharmaceuticals INC | $269.21 | 2021-2025 | Nuplazid |
| Eisai INC. | $251.06 | 2022-2025 | |
| Harmony Biosciences LLC | $244.83 | 2022-2025 | Wakix |
| Neurocrine Biosciences, INC. | $238.34 | 2021-2024 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $221.97 | 2021-2025 | |
| Argenx US, INC. | $201.33 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $200.14 | 2023-2025 | |
| Livanova USA, INC. | $193.05 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Boston Scientific Corporation | $185.97 | 2019-2025 | Wavewriter Alpha Prime 16, Vercise |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $174.74 | 2021-2025 | Gocovri, Gocovri, Apokyn |
| Lundbeck LLC | $153.89 | 2021-2025 | Vyepti |
| Sk Life Science, INC. | $135.87 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $130.03 | 2021-2025 | Austedo Xr, Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $128.58 | 2021 | |
| Avanir Pharmaceuticals, INC. | $128.53 | 2021-2022 | |
| Neurelis, INC. | $127.57 | 2021-2025 | Valtoco |
| Kyowa Kirin, INC. | $126.09 | 2021-2024 | Nourianz |
| Otsuka America Pharmaceutical, INC. | $119.14 | 2023-2025 | Rexulti, Nuedexta |
| Amgen INC. | $118.47 | 2021-2025 | Uplizna |
| Axsome Therapeutics, INC. | $116.07 | 2023-2025 | Sunosi |
| Avion Pharmaceuticals | $111.97 | 2022-2023 | Dhivy |
| Inspire Medical Systems, INC. | $90.09 | 2023-2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $79.73 | 2022 | |
| Ge Healthcare | $79.49 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $77.19 | 2023-2024 | Aptiom |
| Celgene Corporation | $73.21 | 2022-2024 | Zeposia |
| Alexion Pharmaceuticals, INC. | $70.06 | 2023-2024 | Ultomiris, Soliris |
| Janssen Pharmaceuticals, INC | $63.45 | 2022 | |
| Vanda Pharmaceuticals INC. | $62.68 | 2025 | Ponvory |
| Merz Pharmaceuticals, LLC | $59.96 | 2023-2024 | Xeomin |
| Tanabe Pharma America, INC. | $48.07 | 2021 | |
| Cala Health, INC. | $47.36 | 2025 | Cala Kiq |
| Horizon Therapeutics Plc | $41.20 | 2022-2023 | Uplizna |
| Corium, LLC | $38.90 | 2023 | Adlarity |
| Ani Pharmaceuticals, INC. | $38.28 | 2023-2024 | Purified Cortrophin Gel |
| Ipsen Biopharmaceuticals, INC | $37.76 | 2022-2023 | Dysport |
| Tg Therapeutics, INC. | $35.35 | 2023-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $32.70 | 2025 | Lumryz |
| Lilly USA, LLC | $30.77 | 2024 | Emgality, Amyvid |
| Sandoz INC. | $27.88 | 2023 | |
| Greenwich Biosciences, INC. | $25.71 | 2021 | |
| Medtronic, INC. | $24.61 | 2022 | |
| Acorda Therapeutics, INC | $23.50 | 2023 | Inbrija |
| Biotronik Nro, INC. | $22.31 | 2025 | Prospera |
| Aucta Pharmaceuticals, INC. | $22.18 | 2025 | Motpoly Xr |
| Abbott Laboratories | $18.74 | 2024 | Proclaim |
| Kedrion Biopharma, INC. | $18.72 | 2024 | Gammaked, Koate, Kedrab |
| Tonix Medicines, INC. | $18.71 | 2025 | Zembrace Symtouch |
| Idorsia Pharmaceuticals US INC | $16.15 | 2023 | Quviviq |
| Allergan, INC. | $15.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.86 | 2021 | |
| Mallinckrodt Hospital Products INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hakam Asaad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.